MORE►
clinical trials
![Anthony Milonas, CEO of Alliance Clinical Network. [Photo: LinkedIn]](https://s24806.pcdn.co/wp-content/uploads/2025/11/AllianceClinicalNetwork_AnthonyMilonas-970-1-940x436.jpg)
Anthony Milonas, CEO of Alliance Clinical Network. [Composite image: DI Studio; courtesy photo]
Alliance Clinical Network Names Former Ascend Aesthetic CEO as Its New Chief Executive
by Sandra Engelland | Nov 20, 2025
Anthony Milonas brings more than two decades of experience leading and scaling multi-site healthcare organizations across North America.
by Quincy Preston |
Oct 14, 2025
The North Texas biotech, which uses AI to accelerate cancer drug development, received FDA feedback to advance a new clinical study targeting a rare childhood brain tumor.
MORE►
by Lance Murray |
Dec 9, 2024
Baltimore-based Secretome—which has a presence at BioLabs at Pegasus Park in Dallas and offices in Plano—said the financing will enable it to initiate clinical trials for its lead asset, STM-01, and further advance its drug development pipeline.
MORE►
by Lance Murray |
Jan 19, 2024
Marc Chamberlain, M.D., has been appointed as the Chief Medical Officer at Starlight Therapeutics.
Starlight Therapeutics is a Dallas-based Lantern Pharma subsidiary focused exclusively on the clinical development of therapies for central nervous system and brain cancers with limited or no effective therapeutic options.
In his role as CMO, Chamberlain will oversee the company’s upcoming clinical trials focused on several serious and complex brain-related conditions: glioblastoma and other high-grade gliomas (aggressive types of brain tumor), brain metastases in adults (secondary brain tumors originating from cancer elsewhere in the body), and two types of pediatric brain tumors — atypical teratoid rhabdoid tumors (ATRT) and diffuse intrinsic pontine glioma (DIPG)....
MORE►
Nicole Small [Photo: Adam Lee/ARPA-H]
The Last Word: Nicole Small On Why the Dallas-Based ARPA-H Hub Is Focused on Clinical Trials
by Quincy Preston | Oct 20, 2023
The Dallas-based customer experience hub of the Advanced Research Projects Agency for Health had its official launch yesterday at Pegasus Park. The hub's first mission: making it easier for Americans from across the country to take part in clinical trials, through the Advancing Clinical Trial Readiness Initiative.
MORE►
by Lance Murray |
Sep 22, 2023
Samuel Barone, M.D., is a former Federal Drug Administration official and leader in the pharmaceutical space.
MORE►
by Nicole Ward, DRC Data Journalist |
Jun 28, 2023
Organic chemist Lynne Faust is a master at helping companies accelerate drug development at STA Pharmaceuticals, a top-tier contract research and development manufacturer. A move to Weatherford, 25 miles west of Fort Worth, didn't just catalyze her career—it also spurred on her long-time passion for competitive horseback riding, making her life a unique mix of test tubes and trotting.
MORE►
by Lance Murray |
Jun 22, 2023
"There are over 10,000 rare diseases that affect millions of people worldwide, and most of them are genetic," notes UT Southwestern's Steven Gray (above, with Susan Iannaccone, M.D.). Testing on a total of eight genetic diseases has been approved for funding by the Bespoke Gene Therapy Consortium and other organizations.
MORE►
Reveles Clinical Services President and CEO R'Kes Starling [Photo: Reveles]
Dallas-based Reveles Launches Platform to Eliminate Research Barriers and Expand Clinical Trial Access
by David Seeley | Apr 20, 2022
Reveles' new DCT management platform broadens access to clinical trials by enabling patients to participate—without leaving their homes.
The technology includes enabling eConsent from existing and potential patients; online video and audio between patients and healthcare providers; direct data collection including real-time data, compliance, and status view featuring eSource, eDiaries, devices, wearables, questionnaires, and surveys; and telemedicine tools.
MORE►
by Dave Moore |
Aug 4, 2020
Virus researchers at UT Southwestern Medical Center have amped up their lab and data work to fight and defeat COVID-19. Here are key takeaways from UTSW's Claire Aldridge, who herself has battled the virus and fully recovered.
MORE►
by Lance Murray |
May 22, 2019
The clinical-stage oncology company develops small molecule drugs to treat kidney cancer and other diseases. Its renal cell carcinoma drug is in a Phase II clinical trial.
MORE►
by Payton Potter |
May 2, 2019
Using a patient's molecular makeup, Caris and Pharmatech aim to find the perfect clinical trial for each cancer patient—and enroll them in as little as 10 days.
MORE►
This image highlights brain regions that showed significant cerebral blood flow increases in the cognitive training group. [Photo courtesy of Center for BrainHealth]
Discovery: Innovative Thinking Study, Cancer Survivors & Clinical Trials, Quake Sensors
by Lance Murray | Dec 1, 2017
Researchers are making discoveries and breakthroughs at laboratories and institutions all across North Texas. Here are some of their stories.
MORE►
![Erica Kosemund, Chief Brand Officer, Choctaw Nation of Oklahoma; Gillian Breidenbach, Chief Partnership Officer, North Texas FWC Organizing Committee; Chief Gary Batton, Chief of Choctaw Nation of Oklahoma; Monica Paul, Executive Director of Dallas Sports Commission and President of North Texas FWC Organizing Committee; John Hobbs, Senior Executive Officer of Communications, Choctaw Nation of Oklahoma; and Heidi Grant, Senior Executive Officer of Commerce Administration, Choctaw Nation of Oklahoma, celebrate Choctaw Casinos & Resorts becoming an Official Dallas World Cup 2026 Host City Supporter. [Photo: North Texas FWC Organizing Committee/Choctaw Casinos & Resorts]](https://s24806.pcdn.co/wp-content/uploads/2025/12/FIFA-Choctaw-dec-2025.jpg)
